Emerging Targets for Therapy in ALD: Lessons from NASH

Scientists describe conserved and distinct pathogenic pathways highlighting therapeutic targets which may be of potential in both alcohol-associated liver disease (ALD) and non-alcoholic fatty liver disease, and those which are unique to each disease.